Novartis Pharmaceuticals is sponsoring a clinical research trial for males and females, ages 18-55 years, with a cartilage injury of partial thickness of one knee. To learn more about knee joint cartilage injuries, click here. This study is designed to assess the efficacy, safety, and tolerability of multiple injections of the study drug (or placebo) over [...]
NOVOCART® 3D Autologous Chondrocyte Implant System U.S. Phase 3 Clinical Trial NOVOCART® 3D is considered an investigational product in the United States (meaning the product has not been approved by the FDA). NOVOCART® 3D has been used in a select few European countries since 2003 to treat more than 17,000 patients with damaged knee cartilage. Within the [...]
Regentis Biomaterials is conducting a pivotal FDA regulated clinical study (research study) to evaluate the safety and efficacy of an investigational device, GelrinC, implanted following a standard microfracture procedure, compared to a historical control group of patients who have undergone microfracture for the treatment of articular cartilage defects of the knee. This is a non-randomized [...]